🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to compare the effects (good and bad) of chemo...
Status
Completed
Location
University of Pittsburgh Medical Center
Start Date
2008-10
Trial ID
NCT00703976
Treatments Being Tested
Purpose: There remains a great need for novel therapeutic agents and treatm...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2005-07
Trial ID
NCT00130689
Treatments Being Tested
This study is a prospective, randomized phase III, to evaluate if in patien...
Status
Active Not Recruiting
Location
Ospedale San Salvatore
Start Date
2021-04-30
Trial ID
NCT04776655
Treatments Being Tested
The aim of this prospective single-centre phase II study is to investigate ...
Status
Completed
Location
KH Rudolfstiftung
Start Date
2006-10
Trial ID
NCT01216345
Treatments Being Tested
This study will assess the safety and pharmacokinetics of adding dulanermin...
Status
Completed
Location
Multiple Locations
Start Date
2006-07
Trial ID
NCT00671372
Treatments Being Tested
The main purpose of this study is to investigate the safety of prexasertib ...
Status
Completed
Location
University of Alabama at Birmingham Medical Center
Start Date
2016-02-24
Trial ID
NCT02555644
Treatments Being Tested
This phase I trial is studying the side effects and best dose of erlotinib ...
Status
Completed
Location
Vanderbilt-Ingram Cancer Center
Start Date
2007-01
Trial ID
NCT00397384
Treatments Being Tested
This is a multi-center, single arm, open-label, multi-agent, localized phar...
Status
Completed
Location
University of Michigan
Start Date
2020-10-07
Trial ID
NCT04065555
Treatments Being Tested
Prevention of critical weight loss. In patients with Squamous Cell Carcinom...
Status
Terminated
Location
Landeskrankenhaus Feldkirch
Start Date
2017-02-03
Trial ID
NCT02236936
The correlation between the values of angiogenesis-related growth factors i...
Status
Completed
Location
EPS Corporation
Start Date
2013-05
Trial ID
NCT01834014